✦ LIBER ✦

Highly potent and selective inhibition of bovine viral diarrhea virus replication by γ-carboline derivatives

✍ Scribed by Mohammed T.A. Salim; Yukinori Goto; Takayuki Hamasaki; Mika Okamoto; Hiroshi Aoyama; Yuichi Hashimoto; Simone Musiu; Jan Paeshuyse; Johan Neyts; Matheus Froeyen; Piet Herdewijn; Masanori Baba

Book ID: 113458449
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 468 KB
Volume: 88
Category: Article
ISSN: 0166-3542
DOI: 10.1016/j.antiviral.2010.09.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

γ-Carboline Derivatives as Potent and Se

γ-Carboline Derivatives as Potent and Selective Inhibitors of Bovine Viral Diarrhea Virus (BVDV) Replication

✍ Masanori Baba; Mohammed Salim; Mika Okamoto; Hiroshi Aoyama; Yuichi Hashimoto; Y 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Potent and selective inhibition of hepat

Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives

✍ Mohammed T.A. Salim; Hiroshi Aoyama; Kazuyuki Sugita; Kouichi Watashi; Takaji Wa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Highly Potent and Selective Inhibition o

Highly Potent and Selective Inhibition of Varicella—Zoster Virus Replication by Bicyclic Furo[2,3-d]pyrimidine Nucleoside Analogues

✍ Erik De Clercq 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 51 KB 👁 2 views

Highly potent and selective inhibition o

Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d]pyrimidine nucleoside analogues

✍ Erik De Clercq 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB 👁 1 views

## Abstract The bicyclic furo[2,3‐__d__]pyrimidine nucleoside analogues represent an entirely new class of fused furopyrimidine derivatives with unprecedented selectivity for varicella‐zoster virus (VZV). From extensive structure‐activity relationship (SAR) studies, the 6‐(__p__‐alkylphenyl)substit

3 Highly selective and potent inhibition

3 Highly selective and potent inhibition of human immunodeficiency virus (HIV) by the novel bicyclam derivative JM31000: E. De Clercq1, N. Yamamoto1, R. Pauwels1, M. Witvrouw1, K. De Vreese1, Z. Debyser1, R. Skerlj3, D. Thornton2, G. Bridger3, G. Henson3 and M. Abrams3 1Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium; 2Johnson Matthey Technology Centre, Sonning Common, Reading RG4 9NH, United Kingdom; and 3Johnson Matthey Pharmaceutical Research, West Chester, Pennsylvania 19380, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 71 KB